$NTLA

$12.28 +$1.02 (9.06%) Close

$NTLA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 140.1M shares outstanding

Who owns NTLA?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 56.8%

ARK Investment Management LLC 12.0% · BlackRock, Inc. 11.0%

Institutional ownership

100.0%

+21.1 pts vs last qtr

Institutional holders

325

+21 vs last qtr

Net shares bought

+32.5M

by institutions in Q2 2026

New / sold out

53 / 32

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Ra Capital Management, L.P. NEW +4.5M
BlackRock, Inc. +3.3M

Biggest sellers in Q2 2026

UBS Group AG −536.6K
Susquehanna International Group, LLP SOLD OUT −521.5K

Who is planning to sell?

Notices of proposed sale, last 12 months

$1.93M

4 notices from 3 people

Shares covered

173.2K

0.12% of the company

Arranged in advance

62%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Leonard John M Officer 10b5-1 $1.12M
Eliana Clark Officer $736K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+93.6%

+14.12% a year

Each share's claim on the business

−48.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $527M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years68% 3–5 years0% 1–3 years17% Under 1 year15%

Quarterly turnover

19.5%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting NTLA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AI ARK Investment Management LLC	16.9M	12.04%	+2.4M (+16.3%)	≤2021	1.9%
Shares held by quarter Peak holding16.9M (Q2'26) Change over 8 quarters+4.6M Share of the company12.040% ARK Investment Management LLC's full portfolio →
B BlackRock, Inc.	15.4M	11.00%	+3.3M (+26.8%)	≤2021	0.0%
Shares held by quarter Peak holding15.4M (Q2'26) Change over 8 quarters+5.6M Share of the company11.000% BlackRock, Inc.'s full portfolio →

ARK Investment Management LLC

16.9M

% of company

12.04%

Change vs last qtr

+2.4M (+16.3%)

Held since

≤2021

BlackRock, Inc.

15.4M

% of company

11.00%

Change vs last qtr

+3.3M (+26.8%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Intellia Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NTLA on Form N-PORT; together they hold 41.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AI ARK Innovation ETF ARK ETF Trust	$107M	10.0M	7.13%	1.92%	July 31, 2026
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$97.4M	5.8M	4.11%	0.91%	June 30, 2026

ARK Innovation ETF

ARK ETF Trust

Position value

$107M

% of company

7.13%

% of the fund

1.92%

As of

July 31, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$97.4M

% of company

4.11%

% of the fund

0.91%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Intellia Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LJ Leonard John M. Insider	1.2M	0.86%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.860% Leonard John M.'s insider activity →
CF Cohen Fred E Insider	216.7K	0.15%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.150% Cohen Fred E's insider activity →

Leonard John M.

Insider

1.2M

% of company

0.86%

Change vs last qtr

—

Held since

—

Cohen Fred E

Insider

216.7K

% of company

0.15%

Change vs last qtr

—

Held since

—

14 more holders behind a free account

See every insider and 5%+ holder of Intellia Therapeutics, Inc..

Comments